Baudin v. AstraZeneca Pharmaceuticals LP, et al
Stanley Baudin and Stanley P. Baudin |
AstraZeneca LP, Merck Sharp & Dohme Corporation and AstraZeneca Pharmaceuticals LP |
3:2018cv01063 |
December 4, 2018 |
US District Court for the Middle District of Louisiana |
Shelly D Dick |
Erin Wilder-Doomes |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on August 26, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 16 NOTICE of TELEPHONE CONFERENCE: The scheduling conference set for 2/7/2019 has been CONVERTED to a Telephone Conference set for 2/7/2019 at 03:00 PM before Magistrate Judge Erin Wilder-Doomes. Counsel participating in the Conference shall call 877-336-1839 using access code 9565780 five minutes prior to conference. (This is a TEXT ENTRY ONLY. There is no hyperlink or PDF document associated with this entry.)(BLR) |
Filing 15 WAIVER OF SERVICE Returned Executed by Stanley P. Baudin. Merck Sharp & Dohme Corporation waiver sent on 1/23/2019, answer due 3/25/2019. (Fontenot, Evan) |
Filing 14 WAIVER OF SERVICE Returned Executed by Stanley P. Baudin. AstraZeneca Pharmaceuticals LP waiver sent on 1/23/2019, answer due 3/25/2019. (Fontenot, Evan) |
Filing 13 WAIVER OF SERVICE Returned Executed by Stanley P. Baudin. AstraZeneca LP waiver sent on 1/23/2019, answer due 3/25/2019. (Fontenot, Evan) |
Set/Reset Deadlines (Court Use Only) (SGO) |
Filing 12 Joint STATUS REPORT by Stanley P. Baudin. (Coffin, Christopher) |
Filing 11 ORDER granting #10 Motion for Extension of Time until 2/6/2019 to File Response to #8 MOTION to Dismiss for Failure to State a Claim . Signed by Chief Judge Shelly D. Dick on 1/23/19. (This is a TEXT ENTRY ONLY. There is no hyperlink or PDF document associated with this entry.) (BKA) |
Filing 10 MOTION for Extension of Time to File Response to #8 MOTION to Dismiss for Failure to State a Claim by Stanley P. Baudin. (Attachments: #1 Proposed Pleading; Order)(Coffin, Christopher) |
Filing 9 Corporate Disclosure Statement by AstraZeneca LP, AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme Corporation identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP.. (Surprenant, Diana) |
Filing 8 MOTION to Dismiss for Failure to State a Claim by AstraZeneca LP, AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme Corporation. (Attachments: #1 Memorandum in Support)(Surprenant, Diana) |
Filing 7 SCHEDULING CONFERENCE ORDER: Scheduling Conference set for 2/7/2019 at 03:00 PM in chambers before Magistrate Judge Erin Wilder-Doomes. Status Report due by 1/24/2019. Signed by Magistrate Judge Erin Wilder-Doomes on 12/19/2018. (KAH) |
Filing 6 NOTICE from Clerk of the Panel stating this case is not appropriate for inclusion in MDL. (SWE) |
Filing 5 ORDER granting in part #4 Unopposed Motion for Extension of Time Within Which to File Responsive Pleadings. Although the motion does not establish good cause for the requested extension, the motion does appear to qualify for relief under Local Rule7(a). Responsive Pleadings due 1/2/2019. Signed by Magistrate Judge Erin Wilder-Doomes on 12/14/2018. (This is a TEXT ENTRY ONLY. There is no hyperlink or PDF document associated with this entry.) (BLR) |
Set/Reset Deadline: Court Use Only. (BLR) |
Filing 4 Unopposed MOTION for Extension of Time Within Which to File Responsive Pleadings by AstraZeneca LP, AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme Corporation. (Attachments: #1 Proposed Pleading;)(Surprenant, Diana) Modified on 12/11/2018 to edit the text (SWE). |
MOTION(S) REFERRED: #4 Unopposed MOTION for Extension of Time Within Which to File Responsive Pleadings. This motion is now pending before the USMJ. (SWE) |
Filing 3 Letter to JPML Panel notifying panel of possible JPML case (SWE) |
Filing 2 Letter to Attorney Christopher L. Coffin regarding John M. Restaino, Jr. who is Co-Counsel for party Stanley P. Baudin. Attorney is not admitted to practice in LAMD. (SWE) |
Filing 1 NOTICE OF REMOVAL from 19th Judicial District Court, Parish of East Baton Rouge, Case Number C-675654. (Filing fee $ 400 receipt number ALAMDC-1870654), filed by Merck Sharp & Dohme Corporation, AstraZeneca LP, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Attachment)(Surprenant, Diana) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Louisiana Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.